查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2024065

焦慮管理設備市場預測—全球產品、治療方法、分銷管道、技術、應用、最終用戶和地區分析——2034年

Anxiety Management Devices Market Forecasts to 2034- Global Analysis By Product, Treatment Modality, Distribution Channel, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

全球焦慮管理設備市場預計到 2026 年將達到 30.9 億美元，並在預測期內以 7.7% 的複合年成長率成長，到 2034 年達到 56.3 億美元。

焦慮管理設備是專為監測、緩解和管理焦慮症相關症狀而設計的醫療或健康技術。這些設備利用神經刺激、生物回饋療法、心率變異性追蹤和引導式放鬆等技術，影響人體對壓力的生理和心理反應。常見的裝置形式包括穿戴式裝置、手持式刺激器和行動連線系統，可提供即時回饋和個人化介入。這些設備廣泛應用於臨床和家庭環境中，為傳統治療方法提供非侵入性、無藥物的替代方案或補充方案，有助於改善患者的治療效果、提高治療依從性並提升整體心理健康水平。

焦慮症盛行率增加

全球焦慮症負擔日益加重，是焦慮管理設備市場的主要驅動力。都市化、高工作壓力、社交孤立和數位疲勞等因素加劇了焦慮相關疾病的激增。不斷擴大的患者群體推動了對便利性、非侵入性且持續治療方案的需求。此外，早期診斷的趨勢和人們對心理健康意識的提高，也促使更多人採用基於設備的治療方法，加速了臨床和居家照護領域的市場成長。

先進設備高成本

科技先進的焦慮管理設備高成本，仍是其廣泛普及的主要障礙。整合神經刺激、人工智慧分析和即時監測系統的設備通常需要大量的製造和研發成本，使其難以負擔，尤其是在新興市場。有限的保險報銷進一步加重了患者的經濟負擔。因此，價格敏感度限制了市場滲透，尤其是在低收入群體中，從而減緩了整體成長。

技術進步

科技的快速發展為市場創造了巨大的成長機會。穿戴式科技、人工智慧和生物回饋療法系統的創新正在提升設備的精準度、易用性和個人化程度。與行動應用和雲端平台的整合實現了即時監測和數據驅動的洞察，從而改善了治療效果。此外，小型化和低成本設備的開發也提高了設備的普及率。這些進步正在推動消費者接受度，而科技正逐漸成為未來市場擴張的關鍵驅動力。

發展中地區意識水準低

在發展中地區，人們對精神疾病及其治療技術的認知不足，嚴重阻礙了市場成長。在許多地區，對精神疾病的偏見仍然普遍存在，導致診斷不足和治療機會有限。此外，缺乏對焦慮管理設備及其益處的了解也阻礙了其普及。醫療基礎設施不足和專業人員匱乏加劇了這項挑戰。這些因素共同作用，阻礙了市場滲透，延緩了產品的普及。

新冠疫情的影響：

新冠疫情對市場產生了深遠的影響，顯著加劇了壓力、焦慮及相關精神疾病的盛行率。社交隔離、經濟不確定性和健康擔憂導致人們對遠距和非侵入性治療方案的需求激增。這加速了穿戴式和家用焦慮管理設備的普及。此外，遠端醫療了設備的整合和監測。然而，供應鏈中斷和經濟限制暫時影響了產品的生產和供應。

在預測期內，醫院領域預計將佔據最大的市場佔有率。

由於醫院擁有先進的醫療基礎設施和眾多專業技術人員，預計在預測期內，醫院將佔據最大的市場佔有率。醫院是診斷、治療和監測焦慮相關疾病的關鍵中心，推動了經臨床檢驗設備的普及應用。將焦慮管理技術與其他治療性介入結合，能夠改善患者的治療效果。此外，病患數量的增加、醫保報銷機制的完善以及多學科醫療團隊的存在，進一步鞏固了醫院在市場上的主導地位。

在預測期內，神經回饋領域預計將呈現最高的複合年成長率。

在預測期內，由於神經回饋技術在訓練大腦活動和改善情緒調節方面的有效性，預計該領域將呈現最高的成長率。這項非侵入性技術能夠提供腦電圖 (EEG) 模式的即時回饋，使患者能夠自我調節焦慮反應。人們對個人化、非藥物治療方法的日益青睞正在推動其應用。此外，技術的進步和臨床療效的證實也增強了醫療專業人員的信心。人們對改善認知功能的需求不斷成長，也進一步促進了該領域的快速發展。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於該地區對心理健康問題的高度重視以及對創新技術的積極應用。該地區受益於研發方面的巨額投資以及主要市場參與者的存在。有利的報銷政策和焦慮管理設備的廣泛應用進一步推動了市場成長。此外，焦慮症盛行率的上升以及非侵入性治療接受度的提高也鞏固了該地區的市場主導地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於人們心理健康意識的提高和可支配收入的增加。快速的都市化和生活方式的改變導致壓力和焦慮水平上升，從而推動了對有效管理解決方案的需求。政府推廣心理健康和數位醫療的措施進一步促進了市場擴張。此外，穿戴式科技和行動醫療平台的日益普及也加速了焦慮管理設備在全部區域的應用。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域分類
    • 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球焦慮管理設備市場：依產品分類

  • 穿戴式裝置
  • 神經刺激裝置
  • 生物回饋療法和神經反饋設備
  • 虛擬實境（VR）設備
  • 視聽放鬆設備
  • 行動連線設備

第6章：全球焦慮管理設備市場：依治療方法

  • 認知行為療法（CBT）設備
  • 冥想和放鬆設備
  • 生物回饋療法治療設備
  • 神經刺激治療設備

第7章：全球焦慮管理設備市場：依通路分類

  • 線上銷售
  • 線下銷售

第8章：全球焦慮管理設備市場：依技術分類

  • 生物回饋療法
  • 神經回饋
  • 電療
  • 基於虛擬實境的療法
  • 基於感測器的監測

第9章：全球焦慮管理設備市場：依應用領域分類

  • 整體焦慮症
  • 恐慌症
  • 社交焦慮症
  • 創傷後壓力症候群（PTSD）
  • 強迫症（OCD）
  • 特定恐懼症
  • 其他用途

第10章：全球焦慮管理設備市場：以最終用戶分類

  • 醫院
  • 專科診所
  • 居家照護環境
  • 復健中心
  • 教育機構

第11章 全球焦慮管理設備市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • Fisher Wallace Laboratories
  • Electromedical Products International
  • Mind Alive Inc.
  • BrainMaster Technologies Inc.
  • Thought Technology Ltd.
  • Mind Media BV
  • Neurobit Systems
  • HeartMath LLC
  • NeuroSky Inc.
  • InteraXon Inc.
  • Emotiv Inc.
  • Neuroelectrics
  • BrainsWay Ltd.
  • Neuronetics Inc.
  • Medtronic plc
Product Code: SMRC35277

According to Stratistics MRC, the Global Anxiety Management Devices Market is accounted for $3.09 billion in 2026 and is expected to reach $5.63 billion by 2034 growing at a CAGR of 7.7% during the forecast period. Anxiety management devices are specialized medical or wellness technologies designed to monitor, alleviate, and regulate symptoms associated with Anxiety Disorders. These devices utilize approaches such as neurostimulation, biofeedback, heart rate variability tracking, and guided relaxation to influence physiological and psychological responses to stress. Common formats include wearable devices, handheld stimulators, and mobile-connected systems that provide real-time feedback and personalized interventions. Widely used in clinical and home settings, they offer non-invasive, drug-free alternatives or complements to traditional therapies, improving patient outcomes, adherence, and overall mental well-being.

Market Dynamics:

Driver:

Rising prevalence of Anxiety Disorders

The increasing global burden of Anxiety Disorders is a primary driver of the anxiety management devices market. Factors such as urbanization, high work pressure, social isolation, and digital fatigue are contributing to a surge in anxiety-related conditions. This growing patient pool is driving demand for accessible, non-invasive, and continuous treatment solutions. Additionally, early diagnosis trends and rising mental health awareness are encouraging individuals to adopt device-based therapies, thereby accelerating market growth across both clinical and homecare environments.

Restraint:

High cost of advanced devices

The high cost associated with technologically advanced anxiety management devices remains a significant barrier to widespread adoption. Devices incorporating neurostimulation, AI-based analytics, and real-time monitoring systems often involve substantial manufacturing and development expenses, making them less affordable, particularly in emerging economies. Limited insurance reimbursement policies further exacerbate the financial burden on patients. As a result, cost sensitivity restricts market penetration, especially among lower-income populations, thereby slowing the overall growth.

Opportunity:

Technological advancements

Rapid technological advancements present substantial growth opportunities in the market. Innovations in wearable technology, artificial intelligence, and biofeedback systems are enhancing device accuracy, usability, and personalization. Integration with mobile applications and cloud-based platforms enables real-time monitoring and data-driven insights, improving treatment outcomes. Furthermore, the development of compact and cost-effective devices is expanding accessibility. These advancements are fostering increased adoption among consumers, positioning technology as a key enabler of future market expansion.

Threat:

Low awareness in developing regions

Low awareness regarding mental health conditions and available treatment technologies poses a significant threat to market growth in developing regions. In many areas, mental health issues remain stigmatized, leading to underdiagnosis and limited treatment-seeking behavior. Additionally, lack of education about anxiety management devices and their benefits restricts adoption. Insufficient healthcare infrastructure and limited access to trained professionals further compound the challenge. These factors collectively hinder market penetration and slow the adoption.

Covid-19 Impact:

The COVID-19 pandemic had a profound impact on the market, significantly increasing the prevalence of stress, anxiety, and related mental health disorders. Social isolation, economic uncertainty, and health concerns led to a surge in demand for remote and non-invasive treatment solutions. This accelerated the adoption of wearable and home-based anxiety management devices. Additionally, the expansion of telehealth services during the pandemic supported device integration and monitoring. However, supply chain disruptions and economic constraints temporarily affected production and accessibility.

The hospitals segment is expected to be the largest during the forecast period

The hospitals segment is expected to account for the largest market share during the forecast period, due to availability of advanced healthcare infrastructure and skilled professionals. Hospitals serve as primary centers for diagnosis, treatment, and monitoring of anxiety-related conditions, ensuring higher adoption of clinically validated devices. The integration of anxiety management technologies with other therapeutic interventions enhances patient outcomes. Moreover, increased patient inflow, access to reimbursement frameworks, and the presence of multidisciplinary care teams further strengthen the dominance of hospitals in the market.

The neurofeedback segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the neurofeedback segment is predicted to witness the highest growth rate, due to effectiveness in training brain activity and improving emotional regulation. This non-invasive technique provides real time feedback on brainwave patterns, enabling patients to self-regulate anxiety responses. Growing preference for personalized and drug-free therapies is boosting its adoption. Additionally, technological improvements and increasing clinical validation are enhancing its credibility among healthcare providers. The rising demand for cognitive performance enhancement further supports the rapid growth of this segment.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to high awareness of mental health issues, and strong adoption of innovative technologies. The region benefits from significant investments in research and development, along with the presence of key market players. Favorable reimbursement policies and widespread availability of anxiety management devices further drive market growth. Additionally, the rising prevalence of anxiety disorders and increasing acceptance of non-invasive treatments contribute to regional dominance.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to increasing awareness of mental health and rising disposable incomes. Rapid urbanization and changing lifestyles are contributing to higher stress and anxiety levels, driving demand for effective management solutions. Government initiatives promoting mental health and digital healthcare adoption further support market expansion. Additionally, the growing penetration of wearable technologies and mobile health platforms is accelerating the adoption of anxiety management devices across the region.

Key players in the market

Some of the key players in Anxiety Management Devices Market include Fisher Wallace Laboratories, Electromedical Products International, Mind Alive Inc., BrainMaster Technologies Inc., Thought Technology Ltd., Mind Media B.V., Neurobit Systems, HeartMath LLC, NeuroSky Inc., InteraXon Inc., Emotiv Inc., Neuroelectrics, BrainsWay Ltd., Neuronetics Inc. and Medtronic plc.

Key Developments:

In March 2026, Medtronic plc expanded its multiyear alliance with GE HealthCare to accelerate next-generation innovation, integrate advanced patient monitoring technologies, and enhance clinical solutions, enabling more efficient workflows, improved patient outcomes, and broader access to connected, data-driven healthcare systems globally.

In February 2026, Medtronic announced its intent to acquire CathWorks for up to $585 million, strengthening its cardiovascular portfolio. The deal builds on their 2022 partnership and integrates AI-based FFRangio technology to enhance coronary disease diagnosis and treatment, pending regulatory approval.

Products Covered:

  • Wearable Devices
  • Neurostimulation Devices
  • Biofeedback & Neurofeedback Devices
  • Virtual Reality (VR) Devices
  • Audiovisual Relaxation Devices
  • Mobile Connected Devices

Treatment Modalities Covered:

  • Cognitive Behavioral Therapy (CBT) Devices
  • Meditation & Relaxation Devices
  • Biofeedback Therapy Devices
  • Neurostimulation Therapy Devices

Distribution Channels Covered:

  • Online Sales
  • Offline Sales

Technologies Covered:

  • Biofeedback
  • Neurofeedback
  • Electrotherapy
  • VR-Based Therapy
  • Sensor-Based Monitoring

Applications Covered:

  • Generalized Anxiety Disorder
  • Panic Disorder
  • Social Anxiety Disorder
  • Post-Traumatic Stress Disorder (PTSD)
  • Obsessive Compulsive Disorder (OCD)
  • Specific Phobias
  • Other Applications

End Users Covered:

  • Hospitals
  • Specialty Clinics
  • Home Care Settings
  • Rehabilitation Centers
  • Educational Institutions

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Anxiety Management Devices Market, By Product

  • 5.1 Wearable Devices
  • 5.2 Neurostimulation Devices
  • 5.3 Biofeedback & Neurofeedback Devices
  • 5.4 Virtual Reality (VR) Devices
  • 5.5 Audiovisual Relaxation Devices
  • 5.6 Mobile Connected Devices

6 Global Anxiety Management Devices Market, By Treatment Modality

  • 6.1 Cognitive Behavioral Therapy (CBT) Devices
  • 6.2 Meditation & Relaxation Devices
  • 6.3 Biofeedback Therapy Devices
  • 6.4 Neurostimulation Therapy Devices

7 Global Anxiety Management Devices Market, By Distribution Channel

  • 7.1 Online Sales
  • 7.2 Offline Sales

8 Global Anxiety Management Devices Market, By Technology

  • 8.1 Biofeedback
  • 8.2 Neurofeedback
  • 8.3 Electrotherapy
  • 8.4 VR-Based Therapy
  • 8.5 Sensor-Based Monitoring

9 Global Anxiety Management Devices Market, By Application

  • 9.1 Generalized Anxiety Disorder
  • 9.2 Panic Disorder
  • 9.3 Social Anxiety Disorder
  • 9.4 Post-Traumatic Stress Disorder (PTSD)
  • 9.5 Obsessive Compulsive Disorder (OCD)
  • 9.6 Specific Phobias
  • 9.7 Other Applications

10 Global Anxiety Management Devices Market, By End User

  • 10.1 Hospitals
  • 10.2 Specialty Clinics
  • 10.3 Home Care Settings
  • 10.4 Rehabilitation Centers
  • 10.5 Educational Institutions

11 Global Anxiety Management Devices Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 Fisher Wallace Laboratories
  • 14.2 Electromedical Products International
  • 14.3 Mind Alive Inc.
  • 14.4 BrainMaster Technologies Inc.
  • 14.5 Thought Technology Ltd.
  • 14.6 Mind Media B.V.
  • 14.7 Neurobit Systems
  • 14.8 HeartMath LLC
  • 14.9 NeuroSky Inc.
  • 14.10 InteraXon Inc.
  • 14.11 Emotiv Inc.
  • 14.12 Neuroelectrics
  • 14.13 BrainsWay Ltd.
  • 14.14 Neuronetics Inc.
  • 14.15 Medtronic plc

List of Tables

  • Table 1 Global Anxiety Management Devices Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Anxiety Management Devices Market Outlook, By Product (2023-2034) ($MN)
  • Table 3 Global Anxiety Management Devices Market Outlook, By Wearable Devices (2023-2034) ($MN)
  • Table 4 Global Anxiety Management Devices Market Outlook, By Neurostimulation Devices (2023-2034) ($MN)
  • Table 5 Global Anxiety Management Devices Market Outlook, By Biofeedback & Neurofeedback Devices (2023-2034) ($MN)
  • Table 6 Global Anxiety Management Devices Market Outlook, By Virtual Reality (VR) Devices (2023-2034) ($MN)
  • Table 7 Global Anxiety Management Devices Market Outlook, By Audiovisual Relaxation Devices (2023-2034) ($MN)
  • Table 8 Global Anxiety Management Devices Market Outlook, By Mobile Connected Devices (2023-2034) ($MN)
  • Table 9 Global Anxiety Management Devices Market Outlook, By Treatment Modality (2023-2034) ($MN)
  • Table 10 Global Anxiety Management Devices Market Outlook, By Cognitive Behavioral Therapy (CBT) Devices (2023-2034) ($MN)
  • Table 11 Global Anxiety Management Devices Market Outlook, By Meditation & Relaxation Devices (2023-2034) ($MN)
  • Table 12 Global Anxiety Management Devices Market Outlook, By Biofeedback Therapy Devices (2023-2034) ($MN)
  • Table 13 Global Anxiety Management Devices Market Outlook, By Neurostimulation Therapy Devices (2023-2034) ($MN)
  • Table 14 Global Anxiety Management Devices Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 15 Global Anxiety Management Devices Market Outlook, By Online Sales (2023-2034) ($MN)
  • Table 16 Global Anxiety Management Devices Market Outlook, By Offline Sales (2023-2034) ($MN)
  • Table 17 Global Anxiety Management Devices Market Outlook, By Technology (2023-2034) ($MN)
  • Table 18 Global Anxiety Management Devices Market Outlook, By Biofeedback (2023-2034) ($MN)
  • Table 19 Global Anxiety Management Devices Market Outlook, By Neurofeedback (2023-2034) ($MN)
  • Table 20 Global Anxiety Management Devices Market Outlook, By Electrotherapy (2023-2034) ($MN)
  • Table 21 Global Anxiety Management Devices Market Outlook, By VR-Based Therapy (2023-2034) ($MN)
  • Table 22 Global Anxiety Management Devices Market Outlook, By Sensor-Based Monitoring (2023-2034) ($MN)
  • Table 23 Global Anxiety Management Devices Market Outlook, By Application (2023-2034) ($MN)
  • Table 24 Global Anxiety Management Devices Market Outlook, By Generalized Anxiety Disorder (2023-2034) ($MN)
  • Table 25 Global Anxiety Management Devices Market Outlook, By Panic Disorder (2023-2034) ($MN)
  • Table 26 Global Anxiety Management Devices Market Outlook, By Social Anxiety Disorder (2023-2034) ($MN)
  • Table 27 Global Anxiety Management Devices Market Outlook, By Post-Traumatic Stress Disorder (PTSD) (2023-2034) ($MN)
  • Table 28 Global Anxiety Management Devices Market Outlook, By Obsessive Compulsive Disorder (OCD) (2023-2034) ($MN)
  • Table 29 Global Anxiety Management Devices Market Outlook, By Specific Phobias (2023-2034) ($MN)
  • Table 30 Global Anxiety Management Devices Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 31 Global Anxiety Management Devices Market Outlook, By End User (2023-2034) ($MN)
  • Table 32 Global Anxiety Management Devices Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 33 Global Anxiety Management Devices Market Outlook, By Specialty Clinics (2023-2034) ($MN)
  • Table 34 Global Anxiety Management Devices Market Outlook, By Home Care Settings (2023-2034) ($MN)
  • Table 35 Global Anxiety Management Devices Market Outlook, By Rehabilitation Centers (2023-2034) ($MN)
  • Table 36 Global Anxiety Management Devices Market Outlook, By Educational Institutions (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.